Efficacy and safety profile of SGLT2 inhibitors in the elderly: How is the benefit/risk balance?

AJ Scheen, F Bonnet - Diabetes & Metabolism, 2023 - Elsevier
Type 2 diabetes mellitus (T2DM) is a highly prevalent health condition in the aging
population. Older adults with T2DM have higher risks of cardiovascular disease, heart failure …
被引用次数：11 相关文章

Efficacy and safety profile of SGLT2 inhibitors in the elderly: How is the benefit/risk balance?

AJ Scheen, F Bonnet - Diabetes & metabolism, 2023 - pubmed.ncbi.nlm.nih.gov
Type 2 diabetes mellitus (T2DM) is a highly prevalent health condition in the aging
population. Older adults with T2DM have higher risks of cardiovascular disease, heart failure …

Efficacy and safety profile of SGLT2 inhibitors in the elderly: how is the benefit/risk balance?

AJ Scheen, F Bonnet - Diabetes & Metabolism, 2023 - europepmc.org
Type 2 diabetes mellitus (T2DM) is a highly prevalent health condition in the aging
population. Older adults with T2DM have higher risks of cardiovascular disease, heart failure …

Efficacy and safety profile of SGLT2 inhibitors in the elderly: How is the benefit/risk balance?

AJ Scheen, F Bonnet - Diabetes & Metabolism, 2023 - hal.science
Type 2 diabetes mellitus (T2DM) is a highly prevalent health condition in the aging
population. Older adults with T2DM have higher risks of cardiovascular disease, heart failure …

Efficacy and safety profile of SGLT2 inhibitors in the elderly: How is the benefit/risk balance?

AJ Scheen, F Bonnet - Diabetes & Metabolism, 2023 - univ-rennes.hal.science
Type 2 diabetes mellitus (T2DM) is a highly prevalent health condition in the aging
population. Older adults with T2DM have higher risks of cardiovascular disease, heart failure …

Efficacy and safety profile of SGLT2 inhibitors in the elderly: How is the benefit/risk balance?

A Scheen, F Bonnet - Diabetes and Metabolism, 2023 - orbi.uliege.be
Type 2 diabetes mellitus (T2DM) is a highly prevalent health condition in the aging
population. Older adults with T2DM have higher risks of cardiovascular disease, heart failure …
[PDF] hal.science

[PDF][PDF] Efficacy and safety profile of SGLT2 inhibitors in the elderly: How is the benefit/risk balance?

AJ Scheen, F Bonnet - Diabetes & Metabolism, 2023 - hal.science
Type 2 diabetes mellitus (T2DM) is a highly prevalent health condition in the aging
population. Older adults with T2DM have higher risks of cardiovascular disease, heart failure …